Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sino Biopharmaceutical ( (HK:1177) ) has shared an announcement.
Sino Biopharmaceutical Limited announced an interim cash dividend of HKD 0.05 per share for the financial year ending December 31, 2025. The ex-dividend date is set for August 29, 2025, with the payment date scheduled for September 23, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may enhance its attractiveness to investors.
The most recent analyst rating on (HK:1177) stock is a Buy with a HK$6.19 price target. To see the full list of analyst forecasts on Sino Biopharmaceutical stock, see the HK:1177 Stock Forecast page.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited operates in the pharmaceutical industry, focusing on the research, development, manufacturing, and sales of a wide range of pharmaceutical products. The company is known for its innovative approach in the healthcare sector, targeting both domestic and international markets.
Average Trading Volume: 175,820,071
Technical Sentiment Signal: Buy
Current Market Cap: HK$139.9B
For detailed information about 1177 stock, go to TipRanks’ Stock Analysis page.